EyePoint said on Thursday an independent safety committee found no new concerns in two late-stage trials of its experimental eye disease ​drug Duravyu and recommended the studies continue ‌unchanged.

Healthy Vision Month in May is a great time for Texans to focus on protecting their vision health and preventing eye disease. To keep eyes healthy, schedule regular eye exams to check for common ...

An expert MD reveals clear insights into cataract surgery, spotlighting the breakthroughs in treatment: "We live in a time of miracle and wonder." The post “What I Wish I’d Known About Cataract ...

In an observational claims database, patients using GLP-1 receptor agonists (GLP-1RAs) had significantly lower risk of ...

PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing disruptive non-viral vectorized gene therapies with minimally-invasive delivery technology, has reported the ...

Purpose The cross-sectional and longitudinal associations between accelerated biological ageing and the risk of cataract and ...

According to MingMed Biotechnology, 1 the QA102-CS201 trial enrolled 150 patients with intermediate atrophic AMD and randomly ...

Retina care in Orange County combines top-tier medical expertise, advanced technology, and compassionate patient service to address complex eye conditions. From macular degeneration to retinal tears, ...

PennVet Study to Evaluate GMP-Grade Metformin Eye Drops in a Canine Model Supporting Human and Veterinary Development Pathways Palm Beach Gardens, FL, May 07, 2026 (GLOBE NEWSWIRE) -- Curative ...

A local retinal surgeon and ophthalmology professor will speak about age-related macular degeneration during a free webinar ...

The buyout, which includes up to $2.15 billion in milestones, will give Bayer control of an eye disease implant that Perfuse ...

National Eye Institute (NEI) scientists have found that the way the retina metabolizes glucose directly controls which genes get switched on and off in light-sensing photoreceptors. The findings ...